UK to fast-track access to critical medicines


Critically ill patients in the UK could receive new medicines before they are formally approved under a new scheme beginning in April. For diseases where no approved treatment exists, or patients who have exhausted other treatment options, doctors will be permitted to prescribe experimental therapies, which will be supplied by companies to the NHS free of charge.

In order to qualify for the Early Access to Medicines Scheme (EAMS), the product must first be designated as a ‘Promising Innovative Medicine’ by the UK Medicines and Healthcare products Regulatory Agency (MHRA). Then, once the MHRA is satisfied that the drug is safe and the potential benefits outweigh the risks, it will issue an EAMS ‘scientific opinion’. The company will then supply the medicine for free until it is officially approved.

One benefit of the scheme to industry is closer liaison with the regulators over requirements of clinical trial design and manufacturing. Firms will also get much earlier access to data about how their drugs perform in real world settings. While this is not a substitute for comprehensive Phase III clinical studies, it provides a route for small companies, patient groups and charities without the necessary funds to attract investment and bring drugs to the market more easily.

The scheme will not replace the existing pathway to European approval for drugs, and once approved, the medicines will still be subject to value judgements from the UK’s National Institute for Health and Care Excellence (Nice).


Related Content

The hunt for innovation

31 January 2014 Premium contentFeature

news image

Big pharma companies are embracing a more open and collaborative approach. Nuala Moran discovers who’s working with whom

Weathering the storm

6 January 2014 Business

news image

Pharmaceutical industry roundup 2013

Most Read

No-frills coats set a trend for designer viruses

26 August 2014 Research

news image

An artificial protein that self-assembles around and protects DNA could be ideal for gene therapy, nanomachines and synthetic...

Rigid molecular wires make electrons fly

29 August 2014 Research

news image

Organic wires conduct electrons 800 times faster than other molecular counterparts by letting them hitch a ride on a vibratio...

Most Commented

Rigid molecular wires make electrons fly

29 August 2014 Research

news image

Organic wires conduct electrons 800 times faster than other molecular counterparts by letting them hitch a ride on a vibratio...

Concerns over chemical treatment of reclaimed fracking fluid

29 August 2014 Research

news image

Current recycling procedure may do more harm than good